Publications by Dr Fiona Douglas - ePrints

Browsing publications by Dr Fiona Douglas.

Newcastle Authors	Title	Year
Dr Fiona Douglas Kate Bailey	Analysis of rare disruptive germline mutations in 2135 enriched BRCA-negative breast cancers excludes additional high-impact susceptibility genes	2022
Dr Fiona Douglas	Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival after Radical Treatment for Localised Prostate Cancer	2015
Dr Fiona Douglas	Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers	2014
Dr Fiona Douglas	Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome	2014
Dr Fiona Douglas	DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers	2014
Dr Fiona Douglas	Lymphocyte Telomere Length Is Long in BRCA1 and BRCA2 Mutation Carriers Regardless of Cancer-Affected Status	2014
Professor Neil Rajan Dr Piotr Pieniazek Paul Hainsworth Dr Fiona Douglas Professor Ruth Plummer et al.	Mesenteric cysts in Gorlin syndrome: a mimic of metastatic disease	2014
Dr Fiona Douglas Alexander Henderson Penny Wilson	Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: Results from the initial screening round of the IMPACT study	2014
Dr Fiona Douglas	Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk	2013
Dr Fiona Douglas Alexander Henderson	Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer	2013
Professor Kofi Oppong Dr Paul Brennan Dr Fiona Douglas Richard Charnley	Pancreatic Cancer Screening - are we doing it right?	2013
Dr Fiona Douglas	Role of Engrailed-2 (EN2) as a prostate cancer detection biomarker in genetically high risk men	2013
Dr Fiona Douglas	Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2	2012
Dr Fiona Douglas	Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers	2012
Dr Fiona Douglas	Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers	2012
Dr Fiona Douglas	Gene-gene interactions in breast cancer susceptibility	2012
Dr Fiona Douglas	Is colorectal surveillance indicated in patients with PTEN mutations?	2012
Dr Fiona Douglas	Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers	2011
Dr Fiona Douglas	Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2	2011
Dr Fiona Douglas	Exploring the link between MORF4L1 and risk of breast cancer	2011
Dr Fiona Douglas Dr Chris Lord	Germline mutations in RAD51D confer susceptibility to ovarian cancer	2011
Dr Fiona Douglas	Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer	2011
Dr Fiona Douglas	Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: Preliminary analysis of the results of the IMPACT study	2011
Dr Elizabeth Jones Dr Fiona Douglas Dr Nicholas Bown	Wilms Tumor Incidence in Children With 2q Terminal Deletions: A Cohort Study	2011
Dr Fiona Douglas Dr Anne-Marie Gerdes	A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population	2010
Dr Fiona Douglas Professor David Neal	The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine	2010
Dr Fiona Douglas Dr Stephen Ball	Tumour risks and genotype-phenotype-proteotype analysis in 358 patients with germline mutations in SDHB and SDHD	2010
Dr John Beesley Dr Anne-Marie Gerdes Dr Fiona Douglas	Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)	2009
Dr Fiona Douglas Dr Petros Perros	SDHB-associated renal oncocytoma suggests a broadening of the renal phenotype in hereditary paragangliomatosis	2009
Dr Anne-Marie Gerdes Dr Fiona Douglas	Common Breast Cancer-Predisposition Alleles Are Associated with Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers	2008
Dr Fiona Douglas	Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: Validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics	2008
Dr Stephen Ball Dr Fiona Douglas Professor Thomas Lennard	Familial endocrine disease: genetics, clinical presentation and management	2006
Dr Stephen Ball Dr Fiona Douglas Professor Thomas Lennard	Familial endocrine disease: genetics, clinical presentation and management	2006
Professor Sir John Burn Dr Fiona Douglas	Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International society for gastrointestinal hereditary tumours collaborative study	2006
Dr Rachel Davies Dr Fiona Douglas	Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers	2006
Dr Fiona Douglas	A randomised comparison of UK genetic risk counselling services for familial cancer: Psychosocial outcomes	2004
Dr Fiona Douglas	Does cascading work in breast cancer families? A critical audit of BRCA1/BRCA2 mutation carriers and their at risk family members	2004
Professor Colin Wilson Clive Griffith Dr Jyotsna Shrimankar Dr Fiona Douglas	Gynaecomastia, neurofibromatosis and breast cancer	2004
Dr Fiona Douglas	Electronic patient records - implications for genetics	2003
Dr Fiona Douglas Dr Ann Curtis	Identification of a truncating mutation in the TES gene in a patient with familial ovarian cancer	2003
Dr Fiona Douglas Michelle Watson Jamie Burn	A descriptive study of UK cancer genetics services: an emerging clinical response to the new genetics	2001
Dr Fiona Douglas	Consent and Confidentiality: the issues that affect Clinical Genetics and the achievement of good practice in this context	2001
Dr Fiona Douglas	Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma	2001
Dr Fiona Douglas	Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma	2001
Dr Fiona Douglas	Mutations in the mitochondrial complex II subunit SDHB cause susceptibility to familial phaeochromocytoma and paraganglioma	2001
Dr Ujjal Mallick Dr John Fenwick Dr Robert James Dr Sarah Johnson Professor Pat Kendall-Taylor et al.	Northern cancer network guidelines for management of thyroid cancer	2000
Dr Ujjal Mallick Dr Helen Lucraft George Proud Dr Petros Perros Dr John Fenwick et al.	Optimizing the management of differentiated thyroid cancer.	2000
Dr Fiona Douglas Dr Sally Lynch	The accuracy of diagnoses as reported in families with cancer: a retrospective study	1999
Dr Fiona Douglas Dr Sally Lynch	The accuracy of diagnoses as reported in families with cancer: A retrospective study	1999